EDAP TMS receives HIFU reimbursement for prostate cancer in France

EDAP TMS (EDAP) announced that the French Ministry of Health has awarded reimbursement for High Intensity Focused Ultrasound procedure for the treatment of prostate cancer in France. Reimbursement in France will specifically cover use of the Focal One Robotic HIFU procedure for eligible patients as a primary treatment of localized prostate cancer as well as a salvage treatment option following radiotherapy.T his final step in the reimbursement pathway follows the positive favorable opinion issued in December 2023 by the French National Authority for Health to include HIFU as a procedure covered under the national universal health system, Social Security following the completion and analysis of the HIFI Study sponsored by the French Urology Association. Coverage became effective on September 1, 2025, and reimbursement details will become available in the near future.